The data indicated that QCHS could reduce CD103+ DC numbers in the experimental colitis mice and decrease the frequency of MHC-II+CD83+ DCs and the levels of IL-12 ex vivo and in vivo, which suggests that QCHS inhibits DC maturation to form immature DCs. The gene discussed is CD83; the disease is colitis.